These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38507322)

  • 41. Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation.
    Vranckx P; Frigoli E; Rothenbühler M; Tomassini F; Garducci S; Andò G; Picchi A; Sganzerla P; Paggi A; Ugo F; Ausiello A; Sardella G; Franco N; Nazzaro M; de Cesare N; Tosi P; Falcone C; Vigna C; Mazzarotto P; Di Lorenzo E; Moretti C; Campo G; Penzo C; Pasquetto G; Heg D; Jüni P; Windecker S; Valgimigli M;
    Eur Heart J; 2017 Apr; 38(14):1069-1080. PubMed ID: 28329389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nationwide trends in acute coronary syndrome by subtype in New Zealand 2006-2016.
    Wang TKM; Grey C; Jiang Y; Jackson RT; Kerr AJ
    Heart; 2020 Feb; 106(3):221-227. PubMed ID: 31672778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term outcomes of patients receiving zotarolimus-eluting stents in ST elevation myocardial infarction, non-ST elevation acute coronary syndrome, and stable angina: data from the Resolute program.
    Widimsky P; Motovska Z; Belardi J; Serruys P; Silber S; Windecker S; Neumann FJ
    Int J Cardiol; 2013 Oct; 168(4):3522-6. PubMed ID: 23706326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics, Management, and Outcome of Transient ST-elevation Versus Persistent ST-elevation and Non-ST-elevation Myocardial Infarction.
    Blondheim DS; Kleiner-Shochat M; Asif A; Kazatsker M; Frimerman A; Abu-Fanne R; Neiman E; Barel M; Levy Y; Amsalem N; Shotan A; Meisel SR
    Am J Cardiol; 2018 Jun; 121(12):1449-1455. PubMed ID: 29699746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current management and quality of life of patients with acute coronary syndrome undergoing percutaneous coronary intervention in Greece: 12-Month results from antiplatelet therapy observational study II (APTOR II).
    Pavlides G; Drossinos V; Dafni C; Altsitzoglou P; Antoniadis A; Manolis AS; Tsioufis C; Goudevenos I; Kochiadakis G; Alexopoulos D
    Hellenic J Cardiol; 2013; 54(4):255-63. PubMed ID: 23912917
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prima-vista multi-vessel percutaneous coronary intervention in haemodynamically stable patients with acute coronary syndromes: analysis of over 4.400 patients in the EHS-PCI registry.
    Bauer T; Zeymer U; Hochadel M; Möllmann H; Weidinger F; Zahn R; Nef HM; Hamm CW; Marco J; Gitt AK
    Int J Cardiol; 2013 Jul; 166(3):596-600. PubMed ID: 22192297
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Post market surveillance registry (PIONEER) of the Yukon Choice PC-Elite Coronary Stent System for percutaneous coronary intervention in Indian acute coronary syndrome population.
    Kastrati A; Sinha N; Chanana BB; Kasturi S; Sinha SK; Vijay Kumar M; Bansal SS; Jose E J; Gill GS; Garg R; Natarajan S; Mariappan P
    Indian Heart J; 2023; 75(1):25-30. PubMed ID: 36567065
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Left main percutaneous coronary intervention in ACS or stable coronary artery disease: acute and long-term results.
    Varani E; Vecchio S; Aquilina M; Vecchi G; Balducelli M; Frassineti V; Margheri M
    Minerva Cardioangiol; 2016 Feb; 64(1):23-33. PubMed ID: 26989947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Trend of clinical features in patients with acute coronary syndrome undergoing emergent percutaneous coronary intervention].
    Zhou JY; Liu C; Zhou P; Tan Y; Li JN; Sheng ZX; Zhao HJ; Song L; Yang YM; Wu Y; Yan HB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Oct; 46(10):790-794. PubMed ID: 30369169
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial.
    Batra G; Renlund H; Kunadian V; James SK; Storey RF; Steg PG; Katus HA; Harrington RA; Gibson CM; Budaj A; Siegbahn A; Wallentin L
    Eur Heart J Acute Cardiovasc Care; 2022 Jun; 11(4):336-349. PubMed ID: 35213721
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The incidence and outcomes of acute coronary syndromes in a central European country: results of the CZECH-2 registry.
    Tousek P; Tousek F; Horak D; Cervinka P; Rokyta R; Pesl L; Jarkovsky J; Widimsky P;
    Int J Cardiol; 2014 May; 173(2):204-8. PubMed ID: 24602321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
    Coleman CI; McKay RG; Boden WE; Mather JF; White CM
    Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
    Chacko L; P Howard J; Rajkumar C; Nowbar AN; Kane C; Mahdi D; Foley M; Shun-Shin M; Cole G; Sen S; Al-Lamee R; Francis DP; Ahmad Y
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e006363. PubMed ID: 32063040
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.
    Miyachi H; Takagi A; Miyauchi K; Yamasaki M; Tanaka H; Yoshikawa M; Saji M; Suzuki M; Yamamoto T; Shimizu W; Nagao K; Takayama M
    Heart Vessels; 2016 Nov; 31(11):1740-1751. PubMed ID: 26758733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.
    Abtan J; Steg PG; Stone GW; Mahaffey KW; Gibson CM; Hamm CW; Price MJ; Abnousi F; Prats J; Deliargyris EN; White HD; Harrington RA; Bhatt DL;
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1905-13. PubMed ID: 27659566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-941 as a promising biomarker for acute coronary syndrome.
    Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
    BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of Long-Term Outcomes in Men versus Women Undergoing Percutaneous Coronary Intervention.
    Murphy AC; Dinh D; Koshy AN; Lefkovits J; Clark DJ; Zaman S; Duffy SJ; Brennan A; Reid C; Yudi MB;
    Am J Cardiol; 2021 Aug; 153():1-8. PubMed ID: 34238448
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a 'target trial'.
    Pufulete M; Harris J; Pouwels K; Reeves BC; Lasserson D; Loke YK; Mumford A; Mahadevan K; Johnson TW
    Open Heart; 2022 Aug; 9(2):. PubMed ID: 35961692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rationale and design of the OPTIMAL-REPERFUSION trial: A prospective randomized multi-center clinical trial comparing different fibrinolysis-transfer percutaneous coronary intervention strategies in acute ST-segment elevation myocardial infarction.
    Chen Z; Wang D; Ma M; Li C; Wan Z; Zhang L; Zhu Y; Wang M; Wang H; He S; Peng Y; Wei J; Huang B; He Y;
    Clin Cardiol; 2021 Apr; 44(4):455-462. PubMed ID: 33634478
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative outcomes after unprotected left main stem percutaneous coronary intervention: a national linked cohort study of 5,065 acute and elective cases from the BCIS Registry (British Cardiovascular Intervention Society).
    Almudarra SS; Gale CP; Baxter PD; Fleming SJ; Brogan RA; Ludman PF; de Belder MA; Curzen NP;
    JACC Cardiovasc Interv; 2014 Jul; 7(7):717-30. PubMed ID: 25060013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.